Takeda Pharmaceutical Company Limited (TYO:4502)

TYO:4502 Revenue

Takeda Pharmaceutical Company had revenue of 1.22T JPY in the quarter ending June 30, 2026, with 10.23% growth. This brings the company's revenue in the last twelve months to 4.62T, up 4.57% year-over-year. In the fiscal year ending March 31, 2026, Takeda Pharmaceutical Company had annual revenue of 4.51T, down -1.66%.

• Revenue (ttm): 4.62T
• Revenue Growth: +4.57%
• P/S Ratio: 1.87
• Revenue / Employee: 98.21M
• Employees: 47,029
• Market Cap: 8.64T

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.51T	-75.85B	-1.66%
Mar 31, 2025	4.58T	317.79B	7.45%
Mar 31, 2024	4.26T	236.28B	5.87%
Mar 31, 2023	4.03T	458.47B	12.85%
Mar 31, 2022	3.57T	371.19B	11.61%
Mar 31, 2021	3.20T	-93.38B	-2.84%
Mar 31, 2020	3.29T	1.19T	56.93%
Mar 31, 2019	2.10T	326.69B	18.45%
Mar 31, 2018	1.77T	38.48B	2.22%
Mar 31, 2017	1.73T	-75.33B	-4.17%
Mar 31, 2016	1.81T	29.55B	1.66%
Mar 31, 2015	1.78T	86.14B	5.09%
Mar 31, 2014	1.69T	134.42B	8.63%
Mar 31, 2013	1.56T	48.34B	3.20%
Mar 31, 2012	1.51T	89.55B	6.31%
Mar 31, 2011	1.42T	-46.58B	-3.18%
Mar 31, 2010	1.47T	-72.37B	-4.70%
Mar 31, 2009	1.54T	163.53B	11.90%
Mar 31, 2008	1.37T	69.64B	5.34%
Mar 31, 2007	1.31T	92.96B	7.67%
Mar 31, 2006	1.21T	89.25B	7.95%
Mar 31, 2005	1.12T	-	-

Data Source: Fiscal.ai Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error